The four-year trial of about 70 children with "dismal prognoses" in eight hospitals across Australia will test the safety and ...

Two decades after a breast cancer vaccine trial, every participant is still alive—an astonishing result for metastatic ...

In a small clinical trial, customized mRNA vaccines against high-risk skin cancers appeared to reduce the risk of cancer recurrence and death by nearly 50 percent over five years when compared with ...

As cervical cancer awareness month concludes, health officials stress the importance of regular screenings and the HPV ...

Five years ago, a group of high-risk skin cancer patients received a bespoke vaccine. The data is finally in, and the results ...

Vaccines that protect against infectious diseases like the flu or pneumonia are commonly made from a weakened form of the ...

By Kamal Choudhury and Mariam Sunny Jan 20 (Reuters) - Moderna and Merck said on Tuesday their experimental personalized ...

Long-term follow-up data from a phase 2b trial of Moderna and MSD's mRNA-based vaccine against melanoma, intismeran autogene (mRNA-4157), show an impressive 49% reduction in the risk of disease ...

Personalised vaccines will be tested on children with untreatable brain tumours as part of a world-first clinical trial ...

The only man in his immediate family to be without a cancer diagnosis, one Lynch syndrome patient made the trip to ...

A new experimental vaccine could slow down triple negative breast cancer and reduce its recurrence after treatment.